Purpose The objective of this review was to explore the potential clinical application of unconventional non-amino acid PET radiopharmaceuticals in patients with gliomas. Methods A comprehensive search strategy was used based on SCOPUS and PubMed databases using the following string: ("perfusion" OR "angiogenesis" OR "hypoxia" OR "neuroinflammation" OR proliferation OR invasiveness) AND ("brain tumor" OR "glioma") AND ("Positron Emission Tomography" OR PET). From all studies published in English, the most relevant articles were selected for this review, evaluating the mostly used PET radiopharmaceuticals in research centers, beyond amino acid radiotracers and 2-[F-18]fluoro-2-deoxy-d-glucose ([F-18]FDG), for the assessment of different biological features, such as perfusion, angiogenesis, hypoxia, neuroinflammation, cell proliferation, tumor invasiveness, and other biological characteristics in patients with glioma. Results At present, the use of non-amino acid PET radiopharmaceuticals specifically designed to assess perfusion, angiogenesis, hypoxia, neuroinflammation, cell proliferation, tumor invasiveness, and other biological features in glioma is still limited. Conclusion The use of investigational PET radiopharmaceuticals should be further explored considering their promising potential and studies specifically designed to validate these preliminary findings are needed. In the clinical scenario, advancements in the development of new PET radiopharmaceuticals and new imaging technologies (e.g., PET/MR and the application of the artificial intelligence to medical images) might contribute to improve the clinical translation of these novel radiotracers in the assessment of gliomas.

Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas / Laudicella, R; Quartuccio, N; Argiroffi, G; Alongi, P; Baratto, L; Califaretti, E; Frantellizzi, V; De Vincentis, G; Del Sole, A; Evangelista, L; Baldari, S; Bisdas, S; Ceci, Francesco; Iagaru, Andrei; Young Italian Association of Nuclear Medicine (AIMN), Group. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - (2021). [10.1007/s00259-021-05352-w]

Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas

Frantellizzi, V;De Vincentis, G;
2021

Abstract

Purpose The objective of this review was to explore the potential clinical application of unconventional non-amino acid PET radiopharmaceuticals in patients with gliomas. Methods A comprehensive search strategy was used based on SCOPUS and PubMed databases using the following string: ("perfusion" OR "angiogenesis" OR "hypoxia" OR "neuroinflammation" OR proliferation OR invasiveness) AND ("brain tumor" OR "glioma") AND ("Positron Emission Tomography" OR PET). From all studies published in English, the most relevant articles were selected for this review, evaluating the mostly used PET radiopharmaceuticals in research centers, beyond amino acid radiotracers and 2-[F-18]fluoro-2-deoxy-d-glucose ([F-18]FDG), for the assessment of different biological features, such as perfusion, angiogenesis, hypoxia, neuroinflammation, cell proliferation, tumor invasiveness, and other biological characteristics in patients with glioma. Results At present, the use of non-amino acid PET radiopharmaceuticals specifically designed to assess perfusion, angiogenesis, hypoxia, neuroinflammation, cell proliferation, tumor invasiveness, and other biological features in glioma is still limited. Conclusion The use of investigational PET radiopharmaceuticals should be further explored considering their promising potential and studies specifically designed to validate these preliminary findings are needed. In the clinical scenario, advancements in the development of new PET radiopharmaceuticals and new imaging technologies (e.g., PET/MR and the application of the artificial intelligence to medical images) might contribute to improve the clinical translation of these novel radiotracers in the assessment of gliomas.
2021
angiogenesis; glioma; neuroinflammation; PET; perfusion; proliferation
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas / Laudicella, R; Quartuccio, N; Argiroffi, G; Alongi, P; Baratto, L; Califaretti, E; Frantellizzi, V; De Vincentis, G; Del Sole, A; Evangelista, L; Baldari, S; Bisdas, S; Ceci, Francesco; Iagaru, Andrei; Young Italian Association of Nuclear Medicine (AIMN), Group. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - (2021). [10.1007/s00259-021-05352-w]
File allegati a questo prodotto
File Dimensione Formato  
Laudicella_Unconventional non-amino acidic_2021.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.95 MB
Formato Adobe PDF
2.95 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1545093
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 17
social impact